We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+1.86%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$54.7B
AUM Growth
+$1.45B
(+2.7%)
Cap. Flow
+$1.02B
Cap. Flow
% of AUM
1.86%
Top 10 Holdings %
Top 10 Hldgs %
17.33%
Holding
3,009
New
39
Increased
2,170
Reduced
725
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$65.3M |
| 2 |
Global Payments
GPN
|
+$40.3M |
| 3 |
Microsoft
MSFT
|
+$37.9M |
| 4 |
L3Harris
LHX
|
+$32.8M |
| 5 |
Amazon
AMZN
|
+$32.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$64.3M |
| 2 |
RHT
Red Hat Inc
RHT
|
+$57.1M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$40M |
| 4 |
WP
Worldpay, Inc.
WP
|
+$39.2M |
| 5 |
LLL
L3 Technologies, Inc.
LLL
|
+$32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.64% |
| 2 | Financials | 15.56% |
| 3 | Healthcare | 12.85% |
| 4 | Consumer Discretionary | 10.31% |
| 5 | Industrials | 10.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Astrana Health
ASTH
$1.69B
| $526K | ﹤0.01% |
+29,825
| New | +$510K |
|
2302
UroGen Pharma
URGN
$2.29B
| $524K | ﹤0.01% |
22,010
+931
| +4% | +$30.4K |
|
2303
Ameresco
AMRC
$1.41B
| $523K | ﹤0.01% |
32,525
+2,981
| +10% | +$43.5K |
|
2304
CRA International
CRAI
$1.11B
| $523K | ﹤0.01% |
12,472
+739
| +6% | +$30.1K |
|
|
ANH
2305
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $522K | ﹤0.01% |
158,325
+12,615
| +9% | +$45.1K |
|
|
ORC
2306
Orchid Island Capital
ORC
$1.29B
| $521K | ﹤0.01% |
18,108
+3,052
| +20% | +$92.6K |
|
|
NEX
2307
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $521K | ﹤0.01% |
85,953
+9,546
| +12% | +$55.9K |
|
2308
Bally's
BALY
$676M
| $519K | ﹤0.01% |
22,750
-530
| -2% | -$13.1K |
|
|
BELFB
2309
Bel Fuse Inc Class B
BELFB
$4.34B
| $517K | ﹤0.01% |
34,381
+1,766
| +5% | +$24.5K |
|
|
EBTC
2310
DELISTED
Enterprise Bancorp
EBTC
| $516K | ﹤0.01% |
17,196
+1,401
| +9% | +$41.3K |
|
2311
Q32 Bio
QTTB
$493M
| $516K | ﹤0.01% |
1,583
+65
| +4% | +$22.1K |
|
2312
Civista Bancshares
CIVB
$596M
| $514K | ﹤0.01% |
23,660
+2,092
| +10% | +$44.7K |
|
2313
Citizens & Northern Corp
CZNC
$446M
| $513K | ﹤0.01% |
19,521
+1,621
| +9% | +$40.5K |
|
2314
Collegium Pharmaceutical
COLL
$1.01B
| $512K | ﹤0.01% |
44,620
+706
| +2% | +$8.06K |
|
2315
Prothena Corp
PRTA
$442M
| $512K | ﹤0.01% |
65,360
-4,322
| -6% | -$38.4K |
|
2316
Amerant Bancorp
AMTB
$1.15B
| $511K | ﹤0.01% |
24,347
+2,904
| +14% | +$53.2K |
|
|
PCSB
2317
DELISTED
PCSB Financial Corporation
PCSB
| $510K | ﹤0.01% |
25,493
+1,848
| +8% | +$36.6K |
|
|
NETI
2318
DELISTED
Eneti Inc.
NETI
| $506K | ﹤0.01% |
8,955
+676
| +8% | +$37.9K |
|
2319
Intrepid Potash
IPI
$453M
| $505K | ﹤0.01% |
15,438
+1,247
| +9% | +$41.7K |
|
|
SEI
2320
Solaris Energy Infrastructure
SEI
$3.63B
| $505K | ﹤0.01% |
37,612
-60
| -0.2% | -$820 |
|
2321
A10 Networks
ATEN
$2.06B
| $504K | ﹤0.01% |
72,670
-270
| -0.4% | -$1.94K |
|
|
ITCI
2322
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $503K | ﹤0.01% |
67,344
+3,740
| +6% | +$35.9K |
|
|
BCOV
2323
DELISTED
Brightcove, Inc.
BCOV
| $503K | ﹤0.01% |
48,043
-175
| -0.4% | -$2.01K |
|
|
PRTY
2324
DELISTED
Party City Holdco Inc.
PRTY
| $503K | ﹤0.01% |
88,026
+7,826
| +10% | +$44.6K |
|
2325
BioCryst Pharmaceuticals
BCRX
$2.37B
| $502K | ﹤0.01% |
175,062
+13,631
| +8% | +$42.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2019 Portfolio in Review
As of Q3 2019, RhumbLine Advisers held 3,009 positions worth $54.7B, up 2.7% from $53.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Trading was light in Q3 2019: portfolio turnover was 3.1%. RhumbLine Advisers opened 39 new positions and exited 55, leaving the 3,009-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2019 buy was Avantor: 187,780 shares worth $2.76M.
- RhumbLine Advisers added most to Fidelity National Information Services in Q3 2019, an estimated $65.3M increase.
- RhumbLine Advisers's biggest Q3 2019 reduction was Leidos, cutting an estimated $15M.
- RhumbLine Advisers fully exited Anadarko Petroleum in Q3 2019, selling an estimated $64.3M.
- RhumbLine Advisers's ten largest holdings make up 17% of its $54.7B portfolio in Q3 2019.
- RhumbLine Advisers opened 39 new positions and closed 55 in Q3 2019.
- RhumbLine Advisers's portfolio value rose 2.7% quarter-over-quarter to $54.7B.
Based on RhumbLine Advisers's 13F filing for Q3 2019, filed 23 Oct 2019.